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I=~l,l=tbelled GkP.l('/,~36)ar~ide wa~ ¢:ros~.linked to a =p~illc binding protein in rat lunll membrane~ u~in~ di~uccinimidyl ~ul~r=tte. A sin~,le radio. 
iat~lled b~ad at M, 65000 wa~ identilied by $DS-PAG[~ after xoluhili~ttion of the li$aod.bindinlt protein complex wlli~:h i~ coa~i~te=tl with the 
pretence or a sinsle cla=~ of bindin[1 ~ite~ ~n rat lutl$ membrane~, Th~ band was undetectahle when I/m~oltl GLP-I [?.o36)amide was included in 
the binding assay. Ha change in the mohilit~ or'the hand wag observed under reducing ~ondition~ su=gesting thai the binding protein in the receptor 
is not part of a larger disulphide.linked prolein, The intensity of the ridiolab~lled protein band wa~ reduced when the incubation with i== |.lobe|led 
GLP-l(?~36)amide was carried out in the presence of guanine nucleotides sugg©stin8 th'~t he G LP, ICI 36)amidc receptor is cot=pied to th~ adenylale 
cyc|ttse syslcnt. 
GLP-I(7 =36),mide; Receptor; Lung; Covalent erode.linking 
I. INTRODUCTION 
Glucagon- l ike peptide-l(7-36)amide (GLP- I )  is a 
postt rans iat ional  processing product o f  proglucagon in 
the mammal ian  intest ine [1-3]. The amino acid se- 
quence of  GLP- I  was kept during evolut ion and is iden- 
tical in different mammals  including man [4-6], This in- 
dicates an important  biological meaning of GLP- I  at 
least in mammals ,  In previous studies, it has beer 
sh own that GLP-1 is released m response to oral glucose 
and potently st imulates the glucose-induced insulin 
secretion [7-9]. Thus,  GLP.1 is considered to be a new 
incretin candidate be,tides the gastric inhibitory peptide 
(GIP) ,  Furthermore,  GLP- I  is a strong inhibitor of the 
pentagastr in-st imulated gastric acid secretion and 
therefore considered to be an enterogastrone candidate 
[10,11], Cor respond ing  to these data, receptors for 
GLP- i  have been identif ied on rat insul inoma.der ived 
R INmSF cells and isolated gastric glands of the rat 
[12,13]. Recently, we demonstrated specific b inding 
sites for GLP.1(7-35)  amide on rat lung membranes  
[14]. The present study describes the use of a covalent 
cross- l inking reagent to further characterize the l igand- 
b ind ing  component  o r the  GLP- I  receptor on rat lung 
membranes .  
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2. MATERIALS  AND METHODS 
2, I, Reagettrx 
GLP-1(7-36)amide was purchased from Peninsula Laboratories 
(St, Helens, Merseyside, UK), Disuccinimidyl suberate was from 
Pierce Europe BV (Oud.Beijerland, The Netherlands), GTP-?.S and 
GDP-t~-S were from Sigma Chemicals (Deisenhofen Germany) t='~l- 
labelled GLP-I ('/-36) :tmide (spec. act, 74 TBqlmmol) was prepared 
as described by G~Ike and Contort [12], 
2,2, Cell~' 
RINmSF cells were grown in plast ic culture bottles under the condb 
lions described by Praz et al, [15] The cells were detached fronl the 
surface of tl~e bottles before experimentation using phosphate- 
buffered saline (NaCl 136 retool/l, KCI 2,7 tnmol/l. Na.HPO,8 8.1 
retool/I, KH 2PO~ 1,5 retool/l: DH 7,3) cont:fining 0,7 ,nmol/l EDTA,, 
Cell concentrations were determined either by using a Neubauer 
haemocytomcter or by measurement or cellular DNA [16]. 
2,3 Membrane preparalion 
Plasma membranes of RINmSF cells were prepared as described 
previously [17], Briefly, approximately 6x 10 a RINmSF cells were 
suspended in 30 ml ice-cold homogenization buffer (Tris-HCI 10 
retool/I, NaCI 30 retool/l, dithiothreitol I retool/l, phenylmethyl- 
sulphonylfluoride (PMSF) 5 gmol/I; pH 7,5) and disrupted using a 
tight-fitting lass-glass homogenizer with six passages at 150 rpm, 
Rat lung membranes were prepared as described in detail previously 
[14], Male albino Wistar rats (200-220 gbody weight) were killed by 
decapitation, tl~e lungs were removed and homogemzed in 
homogenization buffet" with an Ultra.Turrax followed by a further 
I~omogenization using a glass-glass homogenizer. 
Tile following steps in the preparation of RINmSF cell plasma 
membranes and rat lung membranes were identical. The I~omogenate 
was layered over a 41o/0 (w/v) sucrose solution and centrifuged for ¢50 
min at 4 ° at 95000 x g, The band at the interface of the layers 
represented the membranes and was collected, d[luted and centrifuged 
for 30 rain at 40000 x g. The pellet was resuspended in a modified 
Krebs-Ringer buffer (KRB) (Tris-HCl 2,5 retool/l, NaCI 120 mmol/I, 
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Fill, I Effect of gluealton.like pel~tide-ltT-;16)itnlidc (G1..1).1(7-36) •
amitle on the cross.lhiking or 'I~I.(~LP- I (7-361amide Io ll~, re~gelilOr ill 
rill hmtl plasma membranes. Equal aliquol~t or membrane~ were 
incubated with tracer in the absence (D} anti presence of 0.1 nmol/I 
(C), I0 nmol#l (B) and I000 nmol#l (A) GLP.ltT-~16},~mtide, 
Experiment was ciirried out its described in section 2, Tile num oers 
show the mobilitles of phosphorylase h (hi, 94000), human ~erum 
albumin (M, 67 0O0), ovalbumin (M, 4~ CO0) and trypsin Inhibitor (M, 
20100), 
MaSO~ 1,2 retool/I, KCI 5 mmol#l, CFI)COONa I~ retool/I; pH 7,4) 
Containing I% (w/v) human serum albumin, 0.1% (w/v) baeitracin 
and EDTA I rnmol/I, frozen in liquid nitrogen and stored at -80"C. 
Protein concentration was determined as described by Bradford [18], 
2,4 Cross.linking e.vperiments 
Plasma membranes (200 ~g) were incubated will~ =~l.labelled 
GLP-1(7-36)amide (approximately 40000 cpm; spec. act. approx, 74 
TBq/mmol) in Hepes buffer (50 retool/I; pH 7,5) containing 0.02% 
(w/v} hunaan serum albumin for 30 rain at 37"C, lncubalions were 
also carried out in the presence of a range of concentrations of 
unlabelled GLP-l(7-36)amide or in the presence of guanine 
nucleotides as indicated. Incubations were terminated by centrifu~a- 
lion (10000 x g for 5 rain at 4"C) and pellets resuspended in ice.cold 
Hepes buffer (10 retool/I; pH 9,0) containing 0.02%0 (w/v) human 
serum albumin. 
A solution of disuccinimidyl suberate in dimethylsulphoxide was 
added to give a 0.1 mM final concentration 17] After incubation for 
10 rain at 4°C the reaction was stopped by addition of ammonium 
acetate solution (final concentration 10 retool/I), Membranes were 
centrifuged (10000 x g for 5 rain at 4°C) and the pellets resuspended 
in Hepes buffer (10 retool/l; pH 7,5) containing 0.02%0 human serum 
albumin, An incubation for 30 rain at 25°C was carried outin order 
to dissociate non-covalently bound ligand, After centrifugation 
(10000 x g for 5 rain at 4°C), the pellets were suspended in sodium 
phosphate buffer (10 retool/I; pH 7,5) containin~ 2%0 (w/v) sodium 
dodecylsulphate (SDS). Samples were boiled for 5 min in the presence 
and absence of 5%0 (v/v) mercaptoethanol, Electrophores~s was car- 
ried out using the discontinuous buffer system described by Laernmli 
[19] with a 4% acrylamide stacking gel and a 1007o acrylamide 
separating el, The gels were calibrated using a molecular wei~,ht 
marker kit from Pharmacia, Uppsala, Sweden. Gels were dried and 
exposed to Kodak type X-Omat AR film for 2 weeks at -80°C using 
an image-i~atcnsifying screen. 
3. RESULTS 
Incubation of lung membranes with tzSI-labelled 
GLP-l(7-36)amide followed by chemical cross-linking 
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Fig. 2 Effect or =uanine nucleotides on the cross-linking of l=~l. 
Gt.P.l(?-36]amide to its receptor in rat lunl~ plasma membranes, 
Equal aliqaots or membranes were incubated as described in section 
2 in tile absence (C) and pre~enee (B) of O, I mmol#l GTP.,~-S and O, I 
mmol/ I  GDP.#.S (A), The numbers show the mobilities of 
ptlOSpltorylas¢ h (M, 94000), human serum albumin (Mr 67000), 
ovalbnmia (M, 43 00O) arid trypsin inhibitor (M, 20 100). 
and solubilization has identified a single ligand-binding 
protein complex of Mr 66000 ± 1000 (n=6) (Fig. 1), 
The intensity of the radiolabelled band was reduced 
when the incubation with tZ~l-labelled GLP-I(7-36) 
amide was carried out in the presence of increasing con- 
centrations of unlabelled GLP.l(7-36)amide. At 1 
#mol/l unlabelled GLP-l(7-36)amide no band was 
detectable anymore (Fig. 1). When experiments were 
carried out in the absence of rat lung membranes no 
radioactive labelled band was detectable in the gel. In- 
cubations carried out in the presence of GTP-3,-S (0.1 
retool/l) or GDP-f3-S (0.1 mmol/l) resulted in a reduc- 
tion of the specific receptor linked tracer binding (Fig. 
2). 
A solubilization of the cross-linked receptor/ligand 
complex under reducing conditions did not lead to a 
change of the motility of the labelled M, 66000 band 
(Fig. 3). 
Previously, we characterized GLP-1 receptors on 
RINm5F plasma membranes by covalent cross-linking 
[17]. Experiments carried out to compare cross-linked 
and solubilized GLP-1 receptor-ligand complexes from 
rat lung and RINmSF membranes revealed no signifi- 
cant difference in the molecular weight of the ligand- 
binding protein complexes (Fig. 4). 
Vasoactive intestinal peptide (VIP) and peptide 
histidine isoleucine (PHI) are able to displace 125I- 
GLP- ] (7-36)amtde from rat lung membranes with a Kd 
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Fi~. 3. Effect or snlubili~alion mld~r reclucm~] conditions on the cross. 
linkintl or ~l.GLP.it'~-36)amid~: to i(s receptor in rat lun8 plasma 
mcmbrm~cs. Solubilixafion was carried out in the presence (A,B) nnd 
absence (C,D) er St';* iv/v) l:l.mercal)lOethanol, Incubations were 
carried out in the absence (B,D) and presence (A,C] of I ~rnol/l 
GLP-ItT-36)~mfide, The mtmbcrs slmw the mobilities of 
pllosphoryhsse h (M, 94 000), human scrum albumin (M, 6"/000] ~md 
ovalbumin (b,1, 43000). 
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Fit~. 4, CompcLrlson or the cross-linkinl! or ==~I.GL.P. l(7-]6)amldc to 
its receptor irl ra( lunll (A,B] and R INmH= (C,D) plasma n~cmbranes, 
Ineubalions were carried out as described insection 2 In Ihe presence 
(A,C} and absence (B,D) of I ,arnol/I GLP.l(7-,]6}amide The 
tmmbers :dlow the mobilitics or phosphorylase b (M, ~4000), human 
serum albumin tM, 6"/000) and ovalbumin (hi, 43000). 
which is 2,5 and 4.7 times less, respectively, than that of 
GLP-IC7-36)amide [14]. We then incubated rat lung 
membranes (1 mg protein/ml) with t~I -VIP  in the 
presence and absence of GLP- l (7-36)amide,  
GLP- l (7 -36)amide did not displace *2~I-VIP from its 
binding to rat lung membranes (data not shown), 
4. DISCUSSION 
Recently, we demonstrated the presence of  a single 
class of high affinity receptors for GLP- l (7-36)amide 
on rat lung membranes [14]. Consistent with this result 
only a single protein with Mr 66000 was affinity- 
labelled using the cross-linking agent disuccinimidyl 
suberate which is reactive towards arnino groups and 
has found widespread application in the characteriza- 
tion of binding proteins for neurohormonal  peptides 
[20-25]. Evidence that the tracer bound to a component 
o f  the GLP-1 receptor was obtained by the fact that 
labelling of the protein was inhibited by increasing con- 
centrations of unlabelled GLP- l (7-36)amide.  
Solubilization of the receptor/l igand complex under 
reducing conditions did not lead to a change of the 
moti l i ty of the labelled band suggesting that the binding 
component  for GLP- l (7-36)amide in rat lung mem- 
branes is not a part of a larger disulphide-linked pro- 
tein. 
Recently, we reported that binding of t2Sl- 
GLP- l (7-36)amide to Lung membranes i decreased in 
the presence of guanine nucleotides [14]. Confirming 
these data, we demonstrate now that incubations in the 
presence of guanine nucleotides resulted in a reduction 
of the specific receptor linked tracer binding. This sup- 
ports the assumption that in rat hmg membranes 
GLP- l (7-36)amide receptors are also linked to the 
adenylate cyclase system. 
The data of this study are very similar to results we 
obtained with GLP-1CT-36)amide receptors from 
RINmSF plasma membranes in a previous study [17]. 
Directly compared both receptors exhibited the same 
molecular weight. Thus, it seems that GLP- l (7-36)-  
amide receptors in R INm5F and rat lung plasma mem- 
branes do not differ due to their biochemical proper- 
ties. 
Interestingly, the binding affinity of GLP- I (7-36)-  
amide on rat lung receptors is 10 times less compared to 
receptors on R INmSF membranes [14]. Furthermore, 
vasoactive intestinal peptide (VIP) and peptide histidine 
isoleucin (PHI)  do not bind to GLP- l (7 -36)amide 
receptors on R INm5F membranes but are able to 
displace Iz~I-GLP-l(7-36)amide f rom rat lung mem- 
branes with a Kd which is only 2.5 and 4.? times, respec- 
tively, less than that of GLP- l (7-36)amide [14] while 
~2SI-VIP is not displaced by GLP- l (7-36)amide from 
rat lung membranes. 
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